Table of Content

Open Access iconOpen Access

ARTICLE

Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation

Hammouda Sherif, Mostafa Khalil, Rabea Omar

Department of Urology, Faculty of Medicine, Benha University, Egypt
Address correspondence to Dr. Mostafa Khall, Department of Urology, Faculty of Medicine, Benha University, Egypt

Canadian Journal of Urology 2017, 24(3), 8838-8846.

Abstract

Introduction: To compare the safety and efficacy of posterior tibial nerve stimulation (PTNS) versus an intradetrusor injection of botulinum toxin type-A (BTX-A) 100 U in the management of refractory idiopathic overactive bladder (OAB).
Materials and methods: We randomized 60 patients with refractory idiopathic OAB to receive an intradetrusor injection of BTX-A 100 U or PTNS. We assessed the patients at baseline, 6 weeks, 3 months, 6 months, and 9 months, and determined their clinical symptoms, overall OAB symptom score, urgency score, quality-of-life score, and urodynamic study parameters.
Results: The two patient groups had similar baseline characteristics. After treatment, the patients in the BTX-A group had significant improvements in all parameters compared to their baseline values. Patients in the PTNS group initially had significant improvements in all parameters, but by 9 months, this was no longer true for most parameters. In general, the improvements were more significant in the BTX group, especially at 9 months. In the BTX-A group, two patients (6.6%) needed clean intermittent catheterization; 3 patients (2 women and 1 man; 10% of patients) had mild hematuria, and 2 patients (6.6%) had urinary tract infections (UTIs). In the PTNS group, local adverse effects included minor bleeding spots and temporary pain.
Conclusions: Intradetrusor injection of BTX-A and PTNS are both effective to manage refractory idiopathic OAB. BTX-A is more effective than PTNS and is also durable, minimally invasive, reversible, and safe, but it also has more side effects.

Keywords

overactive bladder, botulinum toxin, posterior tibial nerve stimulation

Cite This Article

APA Style
Sherif, H., Khalil, M., Omar, R. (2017). Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation. Canadian Journal of Urology, 24(3), 8838–8846.
Vancouver Style
Sherif H, Khalil M, Omar R. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation. Can J Urology. 2017;24(3):8838–8846.
IEEE Style
H. Sherif, M. Khalil, and R. Omar, “Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation,” Can. J. Urology, vol. 24, no. 3, pp. 8838–8846, 2017.



cc Copyright © 2017 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 186

    View

  • 152

    Download

  • 0

    Like

Share Link